首页> 外文学位 >Crystallographic studies of thymidylate synthase: Structure of a mammalian enzyme and analyses of invariant non-catalytic residues in a bacterial enzyme.
【24h】

Crystallographic studies of thymidylate synthase: Structure of a mammalian enzyme and analyses of invariant non-catalytic residues in a bacterial enzyme.

机译:胸苷酸合酶的晶体学研究:哺乳动物酶的结构和细菌酶中不变的非催化残基的分析。

获取原文
获取原文并翻译 | 示例

摘要

Thymidylate synthase (TS, EC 2.1.1.45) is the enzyme responsible for the synthesis of 2'-deoxythymidine 5'-monophosphate (dTMP), using 2'-deoxyuridine 5'-monophosphate (dUMP) as the substrate and 5,10-methylene-5,6,7,8-tetrahydrofolate (CH 2H4 folate) as both carbon donor and reductant. Inhibition of TS stops growth of rapidly dividing cells, and for decades TS inhibitors such as 5-fluorouracil, and more recently folyl-analogs, have been used as anticancer drugs. However, prior to my studies, there were no structures available of any ligand-bound mammalian TS. In this dissertation I present the crystal structure of rat TS bound to the substrate dUMP and the anticancer drug Tomudex. Unexpectedly, the enzyme has an open conformation, with ligands bound but no covalent adduct between the catalytic cysteine (Cys 189) and the nucleotide, unlike that reported for the same complex with the E. coli enzyme. Three changes in amino acid sequence between the E. coli and rat TS proteins, namely ecT78 → R101, ecW83 → rN106 and ecV262 → rM305, result in loss of van der Waals contacts with Tomudex. These changes coupled with the loss of a hydrogen bond between the Tomudex 2-quinazoline position, which has been changed from the amino group of the cofactor to a methyl group, suggest that Tomudex may inhibit mammalian TS by stabilizing the open conformation.;In a second project, I have studied the role of two conserved residues, K48 and R166 in catalysis of E. coli TS. Mutation of each of these residues to glutamine produces nearly inactive proteins. Crystallographic analyses of K48Q and R166Q suggest that the loss of these charged groups reduces binding of the ternary covalent intermediate. Superposition of the mutated structures with a previously determined wild type structure containing a close analog of this intermediate (TS-FdUMP-CH2H4 folate), reveals that the mutants are either more open or distorted, and therefore unable to contact the ligands properly. Both Km and kcat are altered for the two enzymes, with Km increasing about 10-fold, and kcat reduced 400-fold (K48Q) and 3,400-fold (R166Q). Taken together, these data suggest that K48Q and R166Q bind weakly one or more of the reaction intermediates, leading to near inactivity.
机译:胸苷酸合酶(TS,EC 2.1.1.45)是负责2'-脱氧胸苷5'-单磷酸(dTMP)合成的酶,使用2'-脱氧尿苷5'-单磷酸(dUMP)作为底物和5,10-亚甲基-5,6,7,8-四氢叶酸(CH 2H4叶酸)作为碳供体和还原剂。 TS的抑制阻止快速分裂的细胞的生长,数十年来,TS抑制剂如5-氟尿嘧啶和最近的叶酰类似物已被用作抗癌药。但是,在我进行研究之前,没有任何与配体结合的哺乳动物TS可用的结构。在本文中,我介绍了与基质dUMP和抗癌药Tomudex结合的大鼠TS的晶体结构。出乎意料的是,该酶具有开放的构象,在催化半胱氨酸(Cys 189)和核苷酸之间结合了配体,但没有共价加合物,这与报道的与大肠杆菌酶相同的复合物不同。大肠杆菌和大鼠TS蛋白之间的氨基酸序列发生三个变化,即ecT78→R101,ecW83→rN106和ecV262→rM305,导致Van der Waals与Tomudex的接触丧失。这些变化加上Tomudex 2-喹唑啉位置之间的氢键丢失(已从辅因子的氨基变为甲基),表明Tomudex可通过稳定开放构象来抑制哺乳动物的TS。第二个项目,我研究了两个保守残基K48和R166在大肠杆菌TS催化中的作用。这些残基中的每一个突变为谷氨酰胺都会产生几乎没有活性的蛋白质。 K48Q和R166Q的晶体学分析表明,这些带电基团的丢失降低了三价共价中间体的结合。突变结构与先前确定的包含该中间体的紧密类似物(TS-FdUMP-CH2H4叶酸)的野生型结构的叠加,表明突变体更加开放或扭曲,因此无法正确接触配体。两种酶的Km和kcat均发生变化,Km增加约10倍,而kcat减少400倍(K48Q)和3400倍(R166Q)。综上所述,这些数据表明,K48Q和R166Q与一种或多种反应中间体的结合较弱,导致几乎没有活性。

著录项

  • 作者单位

    The University of Arizona.;

  • 授予单位 The University of Arizona.;
  • 学科 Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 138 p.
  • 总页数 138
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号